An Observational Study Suggests That Natural HAdV-36 Infection Decreases Blood Glucose Levels without Affecting Insulin Levels in Obese Young Subjects

Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-...

Full description

Saved in:
Bibliographic Details
Published inViruses Vol. 16; no. 6; p. 922
Main Authors Matia-Garcia, Inés, Ocampo-Galeana, Jorge Adalberto, Muñoz-Valle, José Francisco, Soñanez-Organis, José Guadalupe, González, Ramón A., Guzmán-Guzmán, Iris Paola, Marino-Ortega, Linda Anahi, Parra-Rojas, Isela
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 05.06.2024
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m2, p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = −10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
AbstractList Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m , = 0.03), and waist circumference (107 vs. 104 cm, = 0.02), insulin levels (21 vs. 16.3 µU/mL, = 0.003), and HOMA-IR (4.6 vs. 3.9, = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = -10.44, = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m2, p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = −10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m[sup.2] , p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = −10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m², p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = −10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m 2 , p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = −10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m2, p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = -10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in animal models and humans, although epidemiological studies remain controversial. Therefore, this study investigated the relationship between HAdV-36 seropositivity and glycemic control in youths. This observational study examined 460 youths (246 with normal weight and 214 obese subjects). All participants underwent assessments for anthropometry, blood pressure, circulating fasting levels of glucose, lipids, insulin, and anti-HAdV-36 antibodies; additionally, the homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. In all, 57.17% of the subjects were HAdV-36 seropositive. Moreover, HAdV-36 seroprevalence was higher in obese subjects compared to their normal weight counterparts (59% vs. 55%). BMI (33.1 vs. 32.3 kg/m2, p = 0.03), and waist circumference (107 vs. 104 cm, p = 0.02), insulin levels (21 vs. 16.3 µU/mL, p = 0.003), and HOMA-IR (4.6 vs. 3.9, p = 0.02) were higher in HAdV-36-positive subjects with obesity compared to seronegative subjects. In the obese group, HAdV-36 seropositivity was associated with a reducing effect in blood glucose levels in a model adjusted for total cholesterol, triglyceride levels, age and sex (β = -10.44, p = 0.014). Furthermore, a statistically significant positive relationship was observed between HAdV-36 seropositivity and insulin levels in the obesity group. These findings suggest that natural HAdV-36 infection improves glycemic control but does not ameliorate hyperinsulinemia in obese subjects.
Audience Academic
Author Ocampo-Galeana, Jorge Adalberto
Muñoz-Valle, José Francisco
Guzmán-Guzmán, Iris Paola
Matia-Garcia, Inés
Marino-Ortega, Linda Anahi
Soñanez-Organis, José Guadalupe
González, Ramón A.
Parra-Rojas, Isela
AuthorAffiliation 1 Obesity and Diabetes Research Laboratory, Faculty of Biological Chemistry Sciences, Autonomous University of Guerrero, Chilpancingo de los Bravo 39087, Guerrero, Mexico
2 Research Institute in Biomedical Sciences, University Center for Health Science, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico
3 Department of Biological and Agricultural Chemistry Sciences, University of Sonora, Campus Navojoa, Navojoa 85880, Sonora, Mexico
4 Research Center in Cellular Dynamics, Research Institute in Basic and Applied Sciences, Autonomous University of the State of Morelos, Cuernavaca 62209, Morelos, Mexico
AuthorAffiliation_xml – name: 2 Research Institute in Biomedical Sciences, University Center for Health Science, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico
– name: 1 Obesity and Diabetes Research Laboratory, Faculty of Biological Chemistry Sciences, Autonomous University of Guerrero, Chilpancingo de los Bravo 39087, Guerrero, Mexico
– name: 3 Department of Biological and Agricultural Chemistry Sciences, University of Sonora, Campus Navojoa, Navojoa 85880, Sonora, Mexico
– name: 4 Research Center in Cellular Dynamics, Research Institute in Basic and Applied Sciences, Autonomous University of the State of Morelos, Cuernavaca 62209, Morelos, Mexico
Author_xml – sequence: 1
  givenname: Inés
  surname: Matia-Garcia
  fullname: Matia-Garcia, Inés
– sequence: 2
  givenname: Jorge Adalberto
  surname: Ocampo-Galeana
  fullname: Ocampo-Galeana, Jorge Adalberto
– sequence: 3
  givenname: José Francisco
  orcidid: 0000-0002-2272-9260
  surname: Muñoz-Valle
  fullname: Muñoz-Valle, José Francisco
– sequence: 4
  givenname: José Guadalupe
  surname: Soñanez-Organis
  fullname: Soñanez-Organis, José Guadalupe
– sequence: 5
  givenname: Ramón A.
  orcidid: 0000-0001-9689-8529
  surname: González
  fullname: González, Ramón A.
– sequence: 6
  givenname: Iris Paola
  orcidid: 0000-0003-1535-4226
  surname: Guzmán-Guzmán
  fullname: Guzmán-Guzmán, Iris Paola
– sequence: 7
  givenname: Linda Anahi
  surname: Marino-Ortega
  fullname: Marino-Ortega, Linda Anahi
– sequence: 8
  givenname: Isela
  orcidid: 0000-0002-9213-8263
  surname: Parra-Rojas
  fullname: Parra-Rojas, Isela
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38932214$$D View this record in MEDLINE/PubMed
BookMark eNqFkstuEzEUhkeoiF5gwQsgS2xgkeLbjMcrFAq0kSK6SITEyvLYx4mjybgdj4P6IjwvTtOGBiFhL2yd853f9vF_Whx1oYOieE3wOWMSf9iQCldYUvqsOCFSyhGXpDx6sj8uTmNcYVxVEosXxTGrJaOU8JPi17hD102EfqMHHzrdotmQ7B2apcUC4hDRfKkH9E0Pqc-5q7H9PmIVmnQOzJZHn8H0oCNE9KkNwaLLNpkQAU1hA21EP_2wDGlAY3df0C1yaUyt7x4Bvz0ecsGPkHJ2lppVBuPL4rnTbYRXD-tZMf_6ZX5xNZpeX04uxtORKRkeRroWzNKmLHUeFQFwwlrSkIZWDdAac2CWV0YCFRpL3DjpOBGlFDUXjTHsrJjsZG3QK3XT-7Xu71TQXt0HQr9Quh-8aUEJ48qsT7UWhlttpNTWllQIzpyU1GWtjzutm9SswRrohtyyA9HDTOeXahE2ihCKJWc0K7x7UOjDbcrdV2sfDbSt7iCkqBgpWSV4Wdf_R7GgNWECb9G3f6GrkPr80zsq35-z6g-10PmxvnMh39FsRdVYSFnxEmfPnBXn_6DytLD2JpvS-Rw_KHjztCn7bjwaMAPvd4DpQ4w9uD1CsNqaW-3NzX4DiJ3rXQ
Cites_doi 10.1371/journal.pone.0023394
10.2337/db07-1313
10.1093/jn/131.10.2794S
10.1111/j.1467-789X.2009.00677.x
10.2337/db07-1311
10.1038/s41366-021-00805-6
10.1038/ijo.2013.72
10.3390/v15071514
10.3109/07853890.2014.935469
10.1038/ijo.2012.6
10.1038/s41598-020-65008-x
10.1210/jc.2014-1863
10.2147/DMSO.S285341
10.4065/82.10.1192
10.1038/ijo.2011.102
10.1093/jn/131.10.3155
10.1038/sj.ijo.0801319
10.1038/oby.2006.222
10.1038/s41366-019-0321-4
10.2337/dc12-1089
10.1042/BSR20180553
10.1038/ijo.2009.196
10.1038/sj.ijo.0803748
10.1038/s41366-021-01062-3
10.1152/ajpendo.00703.2010
10.1038/s41387-019-0085-x
ContentType Journal Article
Copyright COPYRIGHT 2024 MDPI AG
2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 by the authors. 2024
Copyright_xml – notice: COPYRIGHT 2024 MDPI AG
– notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 by the authors. 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.3390/v16060922
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database


AGRICOLA

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1999-4915
ExternalDocumentID oai_doaj_org_article_7cf5eef2aa7c4dac99add527743f992f
PMC11209432
A799645089
38932214
10_3390_v16060922
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GeographicLocations Mexico
United States--US
GeographicLocations_xml – name: Mexico
– name: United States--US
GrantInformation_xml – fundername: Consejo Nacional de Humanidades, Ciencias y Tecnologías
  grantid: 238868
– fundername: CONAHCYT
  grantid: 238868
GroupedDBID ---
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACUHS
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
TR2
TUS
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
PMFND
3V.
7U9
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c530t-a873d2b55aaaa61eef7dd1b1b26be2804e3d46c9e27a090bf9f417597847bcc3
IEDL.DBID M48
ISSN 1999-4915
IngestDate Wed Aug 27 01:27:31 EDT 2025
Thu Aug 21 18:32:17 EDT 2025
Tue Aug 05 09:41:49 EDT 2025
Tue Aug 05 11:03:17 EDT 2025
Fri Jul 25 11:51:16 EDT 2025
Tue Jun 17 22:08:45 EDT 2025
Tue Jun 10 21:04:40 EDT 2025
Mon Jul 21 06:03:53 EDT 2025
Tue Jul 01 01:53:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords glycemia
insulin resistance
obesity
adenovirus 36
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-a873d2b55aaaa61eef7dd1b1b26be2804e3d46c9e27a090bf9f417597847bcc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-2272-9260
0000-0001-9689-8529
0000-0002-9213-8263
0000-0003-1535-4226
0000-0001-8639-4255
OpenAccessLink https://www.proquest.com/docview/3072743436?pq-origsite=%requestingapplication%
PMID 38932214
PQID 3072743436
PQPubID 2032319
ParticipantIDs doaj_primary_oai_doaj_org_article_7cf5eef2aa7c4dac99add527743f992f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11209432
proquest_miscellaneous_3153674588
proquest_miscellaneous_3072813708
proquest_journals_3072743436
gale_infotracmisc_A799645089
gale_infotracacademiconefile_A799645089
pubmed_primary_38932214
crossref_primary_10_3390_v16060922
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240605
PublicationDateYYYYMMDD 2024-06-05
PublicationDate_xml – month: 6
  year: 2024
  text: 20240605
  day: 5
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Viruses
PublicationTitleAlternate Viruses
PublicationYear 2024
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_13
Peddibhotla (ref_26) 2019; 9
ref_12
Wang (ref_21) 2008; 57
Sapunar (ref_17) 2020; 44
Akheruzzaman (ref_27) 2022; 46
Trovato (ref_15) 2009; 33
Rogers (ref_22) 2008; 57
Dhurandhar (ref_1) 2001; 131
ref_18
Cancelier (ref_7) 2021; 45
Krishnapuram (ref_20) 2013; 37
Mitra (ref_2) 2010; 11
Atkinson (ref_10) 2014; 38
Na (ref_16) 2012; 36
Dhurandhar (ref_6) 2002; 132
(ref_25) 2021; 14
Pasarica (ref_5) 2006; 14
Voss (ref_14) 2014; 99
ref_24
Krishnapuram (ref_8) 2011; 300
Rogers (ref_23) 2008; 32
Dhurandhar (ref_3) 2000; 24
(ref_11) 2013; 2013
Lin (ref_9) 2013; 36
Almgren (ref_19) 2014; 46
Atkinson (ref_4) 2007; 82
References_xml – ident: ref_24
  doi: 10.1371/journal.pone.0023394
– volume: 57
  start-page: 1805
  year: 2008
  ident: ref_21
  article-title: Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling
  publication-title: Diabetes
  doi: 10.2337/db07-1313
– volume: 131
  start-page: 2794S
  year: 2001
  ident: ref_1
  article-title: Infectobesity: Obesity of Infectious Origin
  publication-title: J. Nutr.
  doi: 10.1093/jn/131.10.2794S
– volume: 11
  start-page: 289
  year: 2010
  ident: ref_2
  article-title: Viral Obesity: Fact or Fiction?
  publication-title: Obes. Rev.
  doi: 10.1111/j.1467-789X.2009.00677.x
– volume: 57
  start-page: 2321
  year: 2008
  ident: ref_22
  article-title: Metabolically Favorable Remodeling of Human Adipose Tissue by Human Adenovirus Type 36
  publication-title: Diabetes
  doi: 10.2337/db07-1311
– volume: 45
  start-page: 1342
  year: 2021
  ident: ref_7
  article-title: Adenovirus 36 Prevalence and Association with Human Obesity: A Systematic Review
  publication-title: Int. J. Obes.
  doi: 10.1038/s41366-021-00805-6
– volume: 38
  start-page: 285
  year: 2014
  ident: ref_10
  article-title: Clinical and Laboratory Characteristics of 1179 Czech Adolescents Evaluated for Antibodies to Human Adenovirus 36
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2013.72
– ident: ref_12
  doi: 10.3390/v15071514
– volume: 46
  start-page: 539
  year: 2014
  ident: ref_19
  article-title: Human Adenovirus-36 Is Uncommon in Type 2 Diabetes and Is Associated with Increased Insulin Sensitivity in Adults in Sweden
  publication-title: Ann. Med.
  doi: 10.3109/07853890.2014.935469
– volume: 37
  start-page: 146
  year: 2013
  ident: ref_20
  article-title: Insulin Receptor-Independent Upregulation of Cellular Glucose Uptake
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2012.6
– ident: ref_13
  doi: 10.1038/s41598-020-65008-x
– volume: 99
  start-page: E1708
  year: 2014
  ident: ref_14
  article-title: Adenovirus 36 Antibodies Associated With Clinical Diagnosis of Overweight/Obesity but Not BMI Gain: A Military Cohort Study
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2014-1863
– volume: 14
  start-page: 477
  year: 2021
  ident: ref_25
  article-title: Presence of Adenovirus-36 DNA in Adipose Tissue of Women: Relationship with Adipocyte Morphology and the Expression of C/EBPβ and HIF-1α
  publication-title: Diabetes Metab. Syndr. Obes. Targets Ther.
  doi: 10.2147/DMSO.S285341
– volume: 82
  start-page: 1192
  year: 2007
  ident: ref_4
  article-title: Viruses as an Etiology of Obesity
  publication-title: Mayo Clin. Proc.
  doi: 10.4065/82.10.1192
– volume: 36
  start-page: 281
  year: 2012
  ident: ref_16
  article-title: Association of Human Adenovirus-36 in Overweight Korean Adults
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2011.102
– volume: 132
  start-page: 3155
  year: 2002
  ident: ref_6
  article-title: Human Adenovirus Ad-36 Promotes Weight Gain in Male Rhesus and Marmoset Monkeys
  publication-title: J. Nutr.
  doi: 10.1093/jn/131.10.3155
– volume: 24
  start-page: 989
  year: 2000
  ident: ref_3
  article-title: Increased Adiposity in Animals Due to a Human Virus
  publication-title: Int. J. Obes.
  doi: 10.1038/sj.ijo.0801319
– volume: 14
  start-page: 1905
  year: 2006
  ident: ref_5
  article-title: Human Adenovirus 36 Induces Adiposity, Increases Insulin Sensitivity, and Alters Hypothalamic Monoamines in Rats
  publication-title: Obesity
  doi: 10.1038/oby.2006.222
– volume: 44
  start-page: 159
  year: 2020
  ident: ref_17
  article-title: Adenovirus 36 Seropositivity Is Related to Obesity Risk, Glycemic Control, and Leptin Levels in Chilean Subjects
  publication-title: Int. J. Obes.
  doi: 10.1038/s41366-019-0321-4
– volume: 36
  start-page: 701
  year: 2013
  ident: ref_9
  article-title: Long-Term Changes in Adiposity and Glycemic Control Are Associated with Past Adenovirus Infection
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1089
– ident: ref_18
  doi: 10.1042/BSR20180553
– volume: 33
  start-page: 1402
  year: 2009
  ident: ref_15
  article-title: Human Obesity Relationship with Ad36 Adenovirus and Insulin Resistance
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2009.196
– volume: 32
  start-page: 397
  year: 2008
  ident: ref_23
  article-title: Human Adenovirus Ad-36 Induces Adipogenesis via Its E4 Orf-1 Gene
  publication-title: Int. J. Obes.
  doi: 10.1038/sj.ijo.0803748
– volume: 46
  start-page: 918
  year: 2022
  ident: ref_27
  article-title: E4orf1-Induced Reduction in Endogenous Insulin Level Is Independent of Pancreas Endocrine Function
  publication-title: Int. J. Obes.
  doi: 10.1038/s41366-021-01062-3
– volume: 300
  start-page: E779
  year: 2011
  ident: ref_8
  article-title: Template to Improve Glycemic Control without Reducing Adiposity or Dietary Fat
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00703.2010
– volume: 9
  start-page: 17
  year: 2019
  ident: ref_26
  article-title: E4orf1 Protein Reduces the Need for Endogenous Insulin
  publication-title: Nutr. Diabetes
  doi: 10.1038/s41387-019-0085-x
– volume: 2013
  start-page: 463194
  year: 2013
  ident: ref_11
  article-title: Adenovirus-36 Seropositivity and Its Relation with Obesity and Metabolic Profile in Children
  publication-title: Int. J. Endocrinol.
SSID ssj0066907
Score 2.3604574
Snippet Human adenovirus-36 (HAdV-36) infection has been linked to obesity, low lipid levels, and improvements in blood glucose levels and insulin sensitivity in...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 922
SubjectTerms adenovirus 36
Adenovirus diseases
Adenovirus Infections, Human - blood
Adenovirus Infections, Human - epidemiology
Adenovirus Infections, Human - virology
Adenoviruses
Adenoviruses, Human
Adolescent
Animal models
Anthropometry
Antibodies
Antibodies, Viral - blood
Blood glucose
Blood Glucose - analysis
Blood levels
Blood pressure
Blood sugar
Body Mass Index
Brief Report
Child
Cholesterol
Complications and side effects
Diagnosis
Enzymes
Epidemiology
Female
Glucose
glycemia
glycemic control
Health aspects
Humans
Hyperinsulinemia
Infections
insulin
Insulin - blood
Insulin Resistance
Lipids
Longitudinal studies
Male
Metabolism
Obesity
Obesity - blood
Obesity in children
Observational studies
Regression analysis
Seroepidemiologic Studies
Serology
seroprevalence
Statistical analysis
triacylglycerols
Triglycerides
Viruses
waist circumference
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiPIMLcggJE5RE78SH1OgLAjKgQX1FtmOTXvJIpJF6h_h9zJjZ6ONkODCHtdjJet5feP9PCbkRYd3o0nuc6ZCnQtdytxyAzWPFjJI7A4Tz8J8PFerL-L9hbzYu-oLOWGpPXBauJPKBel9YMZUTnTGaQ0eKRmgFh60ZgGjL-S8XTGVYrDCmi_1EeJQ1J_8LAGnF5qxRfaJTfr_DMV7uWjJk9xLPGd3yO0JMdImvekhueH7u-RmukPy-h751fT0k533VkESqYHX9PP2G_51NND1pRnpuYn9Neiq6b7mXNF3Ewerp68jbhz8QE-Rw07fJg47_YBsooHiPu1mO9Im8j4gz8HUyF7fCVzh4z1MiHEDHmtxZ2e4T9Znb9avVvl02ULuJC_G3IBSOmalNPBRJSx51XWlLS1T1rO6EJ53QjntWWUKXdiggwDoAUWoqKxz_AE56De9f0Ro7UBXMngeCi9q2WnflZUytZfCycB9Rp7vdNB-Ty01WihFUFHtrKiMnKJ2ZgHsgh2_ANtoJ9to_2UbGXmJum3RV0GBzkxHDuA9setV21RQ7QmAqDojxwtJ8DG3HN5ZRzv5-NBCdISSnguuMvJsHsaZyFvr_WabZOqSV0X9FxlIOqrCE8MZeZgMbv7ZCCcZK0VG6oUpLtZlOdJfXcYu4SWeihacPf4fK3lEbjFAc5EjJ4_Jwfhj658AGhvt0-h4vwHqWja5
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t2UggxC4hQ18SvxCW2BsiAoBxa0t8h27LaXpDTZSv0j_F5mnGxohNQc47Hs3Xl4ZvJ5hpA3NfZGk9ynTIUyFTqXqeUGYh4tZJBYHSbehfl2rJY_xZe1XI8Jt26EVW5tYjTUdeswR34AsggBFBdcvTv_nWLXKPy6OrbQuE3uYOkyhHQV6yngUhj5DdWEOIT2B5c5eOuZZmx2BsVS_f8b5Gsn0hwtee34OXpA7o9-I10MjH5IbvnmEbk7dJK8ekz-LBr63U4ZVqBEgOAV_bE5wQ9IHV2dmp4em1hlgy4X9a-UK_p5RGI19EP0Hjvf0UNEstNPA5KdfkVMUUcxW9tuerqI6A847WBqxLBvCc5weQ8TovWAZS3md7onZHX0cfV-mY4tF1InedanBlhTMyulgUfl3oeirnObW6asZ2UmPK-FctqzwmQ6s0EHAQ4IhKKisM7xp2SnaRu_S2jpjClk8DxkXpSy1r7OC2VKL4WTgfuEvN7yoDofCmtUEJAgo6qJUQk5RO5MBFgLO75oL06qUbWqwgUJG2WwnhO1cVqDzZYM_FoetGYhIW-RtxVqLDDQmfHiAewTa19ViwJiPgGOqk7I_owSNM3Nh7fSUY2a3lX_5DIhr6ZhnInotca3m4GmzHmRlTfQwNGjCrw3nJBng8BNPxudSsZykZByJoqz_2U-0pydxlrhOd6NFpzt3bz35-QeA28tYuDkPtnpLzb-BXhbvX0ZVeovDvssdg
  priority: 102
  providerName: ProQuest
Title An Observational Study Suggests That Natural HAdV-36 Infection Decreases Blood Glucose Levels without Affecting Insulin Levels in Obese Young Subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/38932214
https://www.proquest.com/docview/3072743436
https://www.proquest.com/docview/3072813708
https://www.proquest.com/docview/3153674588
https://pubmed.ncbi.nlm.nih.gov/PMC11209432
https://doaj.org/article/7cf5eef2aa7c4dac99add527743f992f
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELaWXSFxQbwJLJVBSJwCiR9xfECohX2A2IKgi3qLHMfeXQml0LSI_hF-LzNOGm0EQvTQQz2WXc-MZ8b-PEPI0wpro0nuYpb5PBY6lXHJDcQ8WkgvMTtMeAtzMs2OT8W7uZzvkG2NzW4Bm7-GdlhP6nT59fnP75tXoPAvMeKEkP3FjxS88EQz2In3wCAp1M8T0V8mZBgAhstlrcNs2gRDw64DsxSy9_-5R18yUkMA5SWLdHiDXO9cSTpueX-T7Lj6FrnaFpfc3Ca_xjX9UPaHrkCJmMEN_bw-wzulhs7OzYpOTUi8QY_H1ZeYZ_RtB86q6ZvgUDauoRMEt9OjFtxO3yPMqKF4gLtYr-g4AELAAELXAGvfElzg8A46hA0Fhi3xyKe5Q2aHB7PXx3FXhSG2kier2AC3KlZKaeCTpc55VVVpmZYsKx3LE-F4JTKrHVMm0UnptQceQJwCdq-0lt8lu_WidvcJza0xSnrHfeJELivtqlRlJndSWOm5i8iTLQ-Kb22ujQJiFGRU0TMqIhPkTk-A6bHDD4vlWdFpW6GslzBRBuNZURmrNWzjkoGry73WzEfkGfK2QLECBlrTvUWAeWI6rGKsIAwU4LvqiOwPKEH57LB5Kx3FVnYL2DYh1ueCZxF53DdjTwS01W6xbmnylKsk_wcNWKNM4VPiiNxrBa7_2-hnMpaKiOQDURysy7ClvjgP6cNTfC4tOHvwP8v9kFxj4MYFcJzcJ7ur5do9AjdsVY7IFTVXI7I3OZh-_DQKhxnwfTRPR0H9fgO6ITWo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJgQviG8CAwwC8RQt8UcSPyDUso2WdQVBQXuzEsfe9pKOpQX1H-G_4H_kzknKIqS9rY_1uXZ65_twfndHyKsSe6NJbkOWuCwUKpZhwXOIeZSQTmJ1GJ8LczhNRt_ExyN5tEH-dLkwCKvsdKJX1OXc4B35DsgiBFBc8OTd2Y8Qu0bh29WuhUYjFgd29QtCtvrteBf4-5qx_b3Z-1HYdhUIjeTRIsxh9ZIVUubwSWJrXVqWcREXLCksyyJheSkSoyxL80hFhVNOgI2FaEukhTEcfvYa2YJ9RKAHtoZ7089fOtWfYKjZlC_iXEU7P2MIDyLFWM_o-d4A_1uACyawD8-8YO_2b5NbraNKB41k3SEbtrpLrjetK1f3yO9BRT8V6ytdoERE4op-XR7jG6uazk7yBZ3mvqwHHQ3K7yFP6LiFflV017urta3pEKHz9EMDnacTBDHVFK-H58sFHXi4CZhXmOpB8x3BKS5vYYJXV7BsgRdK9X0yuwpuPCCb1byyjwjNTJ6n0lnuIisyWSpbxmmSZ1YKIx23AXnZ8UCfNZU8NERAyCi9ZlRAhsidNQEW3_ZfzM-PdXuWdWqchI0yWM-IMjdKgZGQDBxp7pRiLiBvkLcaVQQw0ORtpgPsE4tt6UEKQaYAz1gFZLtHCUfb9Ic76dCtaqn1v4MQkBfrYZyJcLnKzpcNTRbzNMouoQFbl6SYqByQh43ArR8bvVjGYhGQrCeKvf-lP1Kdnvji5DEmYwvOHl--9-fkxmh2ONGT8fTgCbnJwFX0ADy5TTYX50v7FFy9RfGsPWCU6Cs-0n8Bgj5rJQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRSAuiDeBBQwCcYqa-JHEB4S6lNKyS0GioN6ixLF395IumxTUP8J_4d8x4zzYCGlv22M9rp3OjGfG-WaGkJcF9kaT3PgssokvVCj9nGcQ8yghrcTqMC4X5tMimn0TH1dytUP-dLkwCKvszkR3UBdrjXfkI5BFCKC44NHItrCIL5Pp29MfPnaQwjetXTuNRkQOzPYXhG_Vm_kEeP2Ksen75buZ33YY8LXkQe1nsJOC5VJm8IlCY2xcFGEe5izKDUsCYXghIq0Mi7NABblVVoC9hchLxLnWHH72CrkacxmiisWrPtaLMOhsChlxroLRzxAChUAxNjB_rkvA_7bgnDEcAjXPWb7pLXKzdVnpuJGx22THlHfItaaJ5fYu-T0u6ee8v9wFSsQmbunXzRG-u6ro8jir6SJzBT7obFx893lE5y0IrKQT57hWpqL7CKKnHxoQPT1EOFNF8aJ4vanp2AFPwNDCVAef7whOcHkDE9zBBcvmeLVU3SPLy-DFfbJbrkvzkNBEZ1ksreE2MCKRhTJFGEdZYqTQ0nLjkRcdD9LTpqZHCrEQMirtGeWRfeROT4BluN0X67OjtNXqNNZWwkYZrKdFkWmlwFxIBi41t0ox65HXyNsUDwtgoM7anAfYJ5bdSscxhJsCfGTlkb0BJSi5Hg530pG2h0yV_lMJjzzvh3EmAudKs940NEnI4yC5gAasXhRjyrJHHjQC1z82-rOMhcIjyUAUB__LcKQ8OXZlykNMyxacPbp478_IdVDk9HC-OHhMbjDwGR0ST-6R3fpsY56Az1fnT512UZJesjb_BQ95bfU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Observational+Study+Suggests+That+Natural+HAdV-36+Infection+Decreases+Blood+Glucose+Levels+without+Affecting+Insulin+Levels+in+Obese+Young+Subjects&rft.jtitle=Viruses&rft.au=Matia-Garcia%2C+In%C3%A9s&rft.au=Ocampo-Galeana%2C+Jorge+Adalberto&rft.au=Mu%C3%B1oz-Valle%2C+Jos%C3%A9+Francisco&rft.au=So%C3%B1anez-Organis%2C+Jos%C3%A9+Guadalupe&rft.date=2024-06-05&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=16&rft.issue=6&rft.spage=922&rft_id=info:doi/10.3390%2Fv16060922&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_v16060922
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon